Prothena Names Wagner Zago as Chief Scientific Officer

Prothena, a late-stage clinical biotechnology company, said pre-market Monday that it named Wagner Zago as chief scientific officer. Dr. Zago has been Prothena’s head of research since 2015.

Dr. Zago joined Prothena in 2012 when the company was founded after spinning out of Elan Pharmaceuticals, first as head of pharmacology and neuropathology and more recently as vice president, head of research. Dr. Zago holds several key patents and has published broadly in the areas of protein immunotherapy and central nervous system disorders, the company said.

By Caroline Williams